https://oxreceptor.com/index.p....hp/circ-sar1a-helps-
Significant progress in the creation of novel and promising COVID-19 drug candidates has been realized over the course of the last three years. Despite this, mutations in SARS-CoV-2 leading to the development of drug-resistant viral strains mandates the design of innovative, potent, and broad-acting therapeutic agents that target varied vulnerabilities in the viral proteins. Two deep learning generative models, working in concert with molecular mod
Synes godt om
Kommentar
Del
